Chronic Lymphocytic Leukemia Therapy Guided by Measurable Residual Disease
Wei-da Wang1, Robert P Gale2, Yang Liang3
1Sun Yet-sen University Cancer Center, Guangzhou, China.
The New England Journal of Medicine
|May 1, 2024
Abstract
No abstract available in PubMed .
More Related Videos
11:29HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells
Published on: July 20, 2016
11.0K
09:02Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
Published on: November 26, 2018
21.1K
